RNA vs SJM · rev $22.6M vs rev $9.05B
Atrium Therapeutics, Inc. Common Stock (RNA) versus JM Smucker Company (SJM) — a side-by-side from cached financials, not a winner call.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
JM Smucker Company (SJM) is a packaged foods company listed on US.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
Latest reported SJM revenue for 2026-04-30 was $9.05B. Net income was -$138.7M. Revenue was up 3.7% from 2025-04-30 to 2026-04-30. SJM currently screens at market cap $11.10B.
RNA currently screens at market cap $217.5M. SJM currently screens at market cap $11.10B.
Not investment advice. Open the RNA and SJM stock pages for the full models.
Not investment advice.